Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Austrian COVID-19 Registry (AGMT_COVID-19)

NCT04351529 is registered in ClinicalTrials.gov with Arbeitsgemeinschaft medikamentoese Tumortherapie as lead sponsor.

NCT NCT04351529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04351529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Austrian COVID-19 Registry (AGMT_COVID-19)
Lead sponsor
Arbeitsgemeinschaft medikamentoese Tumortherapie
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2020
Completion date
December 31, 2021
Enrollment
1,000 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, infectious disease